The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.
Metastatic Ewing Sarcoma carries a poor prognosis, and novel therapeutics to prevent and treat metastatic disease are greatly needed. Recent evidence demonstrates that tumor-associated macrophages in Ewing Sarcoma are associated with more advanced disease. While some macrophage phenotypes (M1) exhib...
Main Authors: | Anthony J Hesketh, Caroline Maloney, Christopher A Behr, Morris C Edelman, Richard D Glick, Yousef Al-Abed, Marc Symons, Samuel Z Soffer, Bettie M Steinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4692435?pdf=render |
Similar Items
-
The Multi-target Effects of CNI-1493: Convergence of Antiamylodogenic and Antiinflammatory Properties in Animal Models of Alzheimer’s Disease
by: Roman Sankowski, et al.
Published: (2016-11-01) -
Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma
by: Michelle P. Kallis, et al.
Published: (2020-04-01) -
Regulation of Metastasis in Ewing Sarcoma
by: Mingli Li, et al.
Published: (2022-10-01) -
EWING SARCOMA: FEATURES OF LYMPHOGENOUS METASTASIS AND PROGNOSTIC FACTORS
by: N. V. Vasilyev, et al.
Published: (2019-11-01) -
Risk Factors for Metastasis at Initial Diagnosis With Ewing Sarcoma
by: Conglin Ye, et al.
Published: (2019-10-01)